Is a 3 mg dose of ivermectin sufficient for a 78.2 kg male with larva migrans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Larva Migrans in a 78.2 kg Male

A single dose of ivermectin 200 μg/kg (approximately 15.6 mg or 5 tablets of 3 mg each) is the recommended treatment for this 78.2 kg male with larva migrans. 1, 2

Dosing Calculation

  • For a 78.2 kg patient:
    • Recommended dose: 200 μg/kg × 78.2 kg = 15,640 μg = 15.6 mg
    • Using 3 mg tablets: 15.6 mg ÷ 3 mg = 5.2 tablets
    • Therefore, 5 tablets of 3 mg ivermectin should be administered

Treatment Approach

  • Ivermectin should be administered as a single oral dose on an empty stomach with water 2
  • According to FDA dosing guidelines, patients weighing 66-79 kg should receive 5 tablets of 3 mg ivermectin 2
  • The American Society of Tropical Medicine and Hygiene recommends ivermectin as a single oral dose of 200 μg/kg for cutaneous larva migrans 1

Efficacy and Response

  • Single-dose ivermectin therapy has shown cure rates of 81-100% for cutaneous larva migrans 3
  • Response rates are higher (98%) in patients with only creeping dermatitis compared to those with associated hookworm folliculitis (66%) 4
  • Improvement of symptoms typically occurs within 24-48 hours of treatment 1
  • Complete resolution of skin lesions typically occurs within 7-14 days 1

Follow-up and Monitoring

  • If symptoms persist after 1 week, re-evaluation is recommended 5
  • In cases of treatment failure, consider:
    1. Administering a second dose of ivermectin
    2. Alternative treatment with albendazole 400 mg daily for 3 days 5
    3. In resistant cases, combination therapy with both ivermectin and albendazole may be effective 6

Important Considerations

  • Exclude co-existing onchocerciasis or loiasis before administering ivermectin 5
  • Ivermectin is generally well-tolerated with few adverse effects 1
  • Bioavailability is increased when taken with food, which increases drug penetration into the epidermis 5
  • No adjustment of ivermectin dosage is required for persons with renal impairment 5

Prevention of Recurrence

  • Avoid walking barefoot on beaches or soil in endemic areas 1
  • Decontaminate bedding and clothing by machine washing and drying using hot cycle 5
  • For persistent or recurrent cases, environmental control measures may be necessary 1

References

Guideline

Mange and Cutaneous Larva Migrans Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of cutaneous larva migrans.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.